vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and LCNB CORP (LCNB). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $23.9M, roughly 1.9× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -19.9%, a 43.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 15.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
ABCL vs LCNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $23.9M |
| Net Profit | $-8.9M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 29.2% |
| Net Margin | -19.9% | 23.7% |
| Revenue YoY | 788.4% | 5.1% |
| Net Profit YoY | 73.9% | -7.6% |
| EPS (diluted) | $-0.03 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $23.9M | ||
| Q3 25 | $9.0M | $23.8M | ||
| Q2 25 | $17.1M | $22.8M | ||
| Q1 25 | $4.2M | $21.5M | ||
| Q4 24 | $5.0M | $22.7M | ||
| Q3 24 | $6.5M | $21.4M | ||
| Q2 24 | $7.3M | $19.3M | ||
| Q1 24 | $10.0M | $17.8M |
| Q4 25 | $-8.9M | $5.7M | ||
| Q3 25 | $-57.1M | $6.9M | ||
| Q2 25 | $-34.7M | $5.9M | ||
| Q1 25 | $-45.6M | $4.6M | ||
| Q4 24 | — | $6.1M | ||
| Q3 24 | $-51.1M | $4.5M | ||
| Q2 24 | $-36.9M | $925.0K | ||
| Q1 24 | $-40.6M | $1.9M |
| Q4 25 | -63.7% | 29.2% | ||
| Q3 25 | -851.8% | 35.6% | ||
| Q2 25 | -290.2% | 31.6% | ||
| Q1 25 | -1479.6% | 25.6% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | -1439.4% | 24.9% | ||
| Q2 24 | -1276.2% | 4.9% | ||
| Q1 24 | -551.5% | 12.5% |
| Q4 25 | -19.9% | 23.7% | ||
| Q3 25 | -637.8% | 29.1% | ||
| Q2 25 | -203.3% | 26.0% | ||
| Q1 25 | -1077.2% | 21.4% | ||
| Q4 24 | — | 27.0% | ||
| Q3 24 | -785.4% | 21.2% | ||
| Q2 24 | -504.3% | 4.8% | ||
| Q1 24 | -408.0% | 10.7% |
| Q4 25 | $-0.03 | $0.40 | ||
| Q3 25 | $-0.19 | $0.49 | ||
| Q2 25 | $-0.12 | $0.41 | ||
| Q1 25 | $-0.15 | $0.33 | ||
| Q4 24 | — | $0.44 | ||
| Q3 24 | $-0.17 | $0.31 | ||
| Q2 24 | $-0.13 | $0.07 | ||
| Q1 24 | $-0.14 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $966.9M | $273.9M |
| Total Assets | $1.4B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $21.6M | ||
| Q3 25 | $83.2M | $35.9M | ||
| Q2 25 | $92.4M | $49.8M | ||
| Q1 25 | $159.3M | $37.7M | ||
| Q4 24 | $156.3M | $35.7M | ||
| Q3 24 | $126.6M | $39.4M | ||
| Q2 24 | $148.3M | $34.9M | ||
| Q1 24 | $123.6M | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $966.9M | $273.9M | ||
| Q3 25 | $964.0M | $269.9M | ||
| Q2 25 | $1.0B | $263.5M | ||
| Q1 25 | $1.0B | $258.7M | ||
| Q4 24 | $1.1B | $253.0M | ||
| Q3 24 | $1.1B | $253.2M | ||
| Q2 24 | $1.1B | $245.2M | ||
| Q1 24 | $1.1B | $233.7M |
| Q4 25 | $1.4B | $2.2B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.4B | $2.3B | ||
| Q1 25 | $1.3B | $2.3B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | $1.4B | $2.3B | ||
| Q2 24 | $1.4B | $2.4B | ||
| Q1 24 | $1.5B | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $34.4M |
| Free Cash FlowOCF − Capex | $-44.6M | $33.4M |
| FCF MarginFCF / Revenue | -99.4% | 140.2% |
| Capex IntensityCapex / Revenue | 21.9% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $34.4M | ||
| Q3 25 | $-52.6M | $14.0M | ||
| Q2 25 | $-32.4M | $5.5M | ||
| Q1 25 | $-11.6M | $2.2M | ||
| Q4 24 | $-108.6M | $93.2M | ||
| Q3 24 | $-28.9M | $11.9M | ||
| Q2 24 | $-30.0M | $54.9M | ||
| Q1 24 | $-41.7M | $-11.9M |
| Q4 25 | $-44.6M | $33.4M | ||
| Q3 25 | $-61.5M | $13.7M | ||
| Q2 25 | $-45.8M | $5.2M | ||
| Q1 25 | $-22.2M | $2.1M | ||
| Q4 24 | $-187.0M | $89.4M | ||
| Q3 24 | $-47.4M | $10.5M | ||
| Q2 24 | $-50.1M | $53.8M | ||
| Q1 24 | $-65.8M | $-12.8M |
| Q4 25 | -99.4% | 140.2% | ||
| Q3 25 | -687.0% | 57.4% | ||
| Q2 25 | -267.9% | 23.0% | ||
| Q1 25 | -524.0% | 10.0% | ||
| Q4 24 | -3702.8% | 394.0% | ||
| Q3 24 | -728.4% | 49.0% | ||
| Q2 24 | -683.8% | 278.6% | ||
| Q1 24 | -661.5% | -71.8% |
| Q4 25 | 21.9% | 4.0% | ||
| Q3 25 | 99.7% | 1.3% | ||
| Q2 25 | 78.2% | 1.0% | ||
| Q1 25 | 251.1% | 0.3% | ||
| Q4 24 | 1552.7% | 16.7% | ||
| Q3 24 | 284.6% | 6.7% | ||
| Q2 24 | 274.6% | 5.9% | ||
| Q1 24 | 242.5% | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | — | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
